EU trade mark deal struck, so what happens now?

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EU trade mark deal struck, so what happens now?

Finally, after five years of debate, there is an agreement on reform to the EU Trade Marks Directive and CTM Regulation. While there is a cautious welcome for what has been agreed, we are likely to enter a new period of adaptation and scrutiny

EU flag

The so-called trilogue of the European Council, Commission and Parliament yesterday struck a deal on reforms to trade mark protection in Europe. As we reported yesterday, the substance of the reforms is probably less than many trade mark users hoped, and the latter stages of the negotiations were characterised by debates about money. There is also a lot of detail that still needs to be fleshed out.

Having said that, initial reaction to the agreement among trade mark groups has been cautiously positive. INTA President J Scott Evans (right) blogged that the Association “welcomes a number of aspects of the agreement” including the reduction in renewal fees, the provisions on goods in transit and the implementation of the IP Translator decision on classification of goods and services. But he added that there were elements of the deal that INTA would be monitoring.

Tove Graulund of Graulund Consulting, who chairs the MARQUES trade mark reform task force, added that elements of the agreement showed that users’ concerns had been listened to, in particular the plans to ensure all EU IP offices have administrative proceedings for trade mark cancellation and the financial incentive to apply for a CTM in just one class, rather than three.

However, EU member states have also got much of what they wanted from the negotiations. Notably, once the reform is implemented, at least €5 of every €100 received in fees by OHIM (which will be renamed the EU IP Office) will be “offset” to national offices to promote trade mark harmonisation. If OHIM continues to run at a significant surplus, this could increase to €10 in every €100. A further €15 in every €100 is earmarked for cooperation projects. That adds up to some nice extra revenue for national IP offices.

OHIM new office

Does that mean everyone is happy? The answer is that there is probably enough in the deal, based on what we have been told about it so far, to ensure the remaining formalities will be passed and it will lead to changes to trade mark practice in Europe.

That will end a process that began more than five years ago, with the Max Planck study (see our topic page for all the ups and downs of the process). But it will mark the beginning of another phase, which will be characterised by adaptation and observation.

Those who will have to adapt are trade mark practitioners and IP offices in Europe, though some countries will see bigger changes than others. And in truth for many trade mark owners and applicants the changes will be relatively minor and will have little impact on their day-to-day practice.

Meanwhile, trade mark users groups will be monitoring closely what happens to the money. The principle of diverting money away from OHIM was widely opposed, but that battle is now lost. Instead, users (some of whom are observers on OHIM’s Board) will want to see evidence that the money is staying in the IP system and being used to improve services for trade mark owners. IP offices in member states are on notice.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article